Search Results - "Cardoso, Evelina"

Therapeutic Drug Monitoring of Targeted Anticancer Protein Kinase Inhibitors in Routine Clinical Use: A Critical Review by Cardoso, Evelina, Guidi, Monia, Blanchet, Benoît, Schneider, Marie Paule, Decosterd, Laurent A., Buclin, Thierry, Csajka, Chantal, Widmer, Nicolas

“…Therapeutic response to oral targeted anticancer protein kinase inhibitors (PKIs) varies widely between patients, with insufficient efficacy of some of them…”
Get full text

Quantification of the next-generation oral anti-tumor drugs dabrafenib, trametinib, vemurafenib, cobimetinib, pazopanib, regorafenib and two metabolites in human plasma by liquid chromatography-tandem mass spectrometry by Cardoso, Evelina, Mercier, Thomas, Wagner, Anna Dorothea, Homicsko, Krisztian, Michielin, Olivier, Ellefsen-Lavoie, Kim, Cagnon, Laurène, Diezi, Manuel, Buclin, Thierry, Widmer, Nicolas, Csajka, Chantal, Decosterd, Laurent

“…A sensitive and selective method of high performance liquid chromatography (HPLC) coupled to tandem mass spectrometry (MS/MS) has been developed for the…”
Get full text

Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland by Bandiera, Carole, Skrabal Ross, Xiomara, Cardoso, Evelina, Wagner, Dorothea, Csajka, Chantal, Olver, Ian, Patterson, Pandora, Suppiah, Vijayaprakash, Gunn, Kate M., Schneider, Marie

“…Not monitoring adherence to oral anticancer therapies (OAT) can lead to poor clinical outcomes, including premature death as reported by Foulon et al. (Acta…”
Get full text

Population Pharmacokinetics of Erlotinib in Patients With Non–small Cell Lung Cancer: Its Application for Individualized Dosing Regimens in Older Patients by Evelina Cardoso, Guidi, Monia, Khoudour, Nihel, Pascaline Boudou-Rouquette, Fabre, Elizabeth, Tlemsani, Camille, Arrondeau, Jennifer, François Goldwasser, Vidal, Michel, Schneider, Marie Paule, Wagner, Anna Dorothea, Widmer, Nicolas, Blanchet, Benoit, Csajka, Chantal

“…Erlotinib is an oral first-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor approved for non–small cell lung cancers (NSCLC) with…”
Get full text

Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer by Rodier, Thomas, Puszkiel, Alicja, Cardoso, Evelina, Balakirouchenane, David, Narjoz, Céline, Arrondeau, Jennifer, Fallet, Vincent, Khoudour, Nihel, Guidi, Monia, Vidal, Michel, Declèves, Xavier, Csajka, Chantal, Alexandre, Jérôme, Cadranel, Jacques, Fabre, Elizabeth, Wislez, Marie, Goldwasser, François, Blanchet, Benoit

“…High interindividual variability (IIV) of the clinical response to epidermal growth factor receptor (EGFR) inhibitors such as osimertinib in non-small-cell…”
Get full text

Infant exposure to Fluvoxamine through placenta and human milk: a case series - A contribution from the ConcePTION project by Monfort, Anaëlle, Cardoso, Evelina, Eap, Chin B, Fischer Fumeaux, Céline J, Graz, Myriam Bickle, Morisod Harari, Mathilde, Weisskopf, Etienne, Gandia, Peggy, Allegaert, Karel, Nordeng, Hedvig, Hascoët, Jean-Michel, Claris, Olivier, Epiney, Manuella, Csajka, Chantal, Guidi, Monia, Ferreira, Ema, Panchaud, Alice

“…Fluvoxamine is widely used to treat depression during pregnancy and lactation. However, limited data are available on its transfer to the fetus or in human…”
Get full text

Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer by Courlet, Perrine, Cardoso, Evelina, Bandiera, Carole, Stravodimou, Athina, Zurcher, Jean-Philippe, Chtioui, Haithem, Locatelli, Isabella, Decosterd, Laurent Arthur, Darnaud, Léa, Blanchet, Benoit, Alexandre, Jérôme, Wagner, Anna Dorothea, Zaman, Khalil, Schneider, Marie Paule, Guidi, Monia, Csajka, Chantal

“…Neutropenia is the most frequent dose-limiting toxicity reported in patients with metastatic breast cancer receiving palbociclib. The objective of this study…”
Get full text

Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data by Bandiera, Carole, Cardoso, Evelina, Locatelli, Isabella, Digklia, Antonia, Zaman, Khalil, Diciolla, Antonella, Cristina, Valérie, Stravodimou, Athina, Veronica, Aedo Lopez, Dolcan, Ana, Sarivalasis, Apostolos, Liapi, Aikaterini, Bouchaab, Hasna, Orcurto, Angela, Dotta-Celio, Jennifer, Peters, Solange, Decosterd, Laurent, Widmer, Nicolas, Wagner, Dorothea, Csajka, Chantal, Schneider, Marie Paule

“…BackgroundThe strengthening or substitution of intravenous cytotoxic chemotherapy cycles by oral targeted anticancer therapies, such as protein kinase…”
Get full text

Effect of Adherence on Pharmacokinetic/Pharmacodynamic Relationships of Oral Targeted Anticancer Drugs by Cardoso, Evelina, Csajka, Chantal, Schneider, Marie P., Widmer, Nicolas

“…The emergence of oral targeted anticancer agents transformed several cancers into chronic conditions with a need for long-term oral treatment. Although cancer…”
Get full text

Safety of medicines during breastfeeding - from case report to modeling: a contribution from the ConcePTION project by Cardoso, Evelina, Guidi, Monia, Nauwelaerts, Nina, Nordeng, Hedvig, Teil, Marie, Allegaert, Karel, Smits, Anne, Gandia, Peggy, Edginton, Andrea, Ito, Shinya, Annaert, Pieter, Panchaud, Alice

“…Despite many research efforts, current data on the safety of medicines during breastfeeding are either fragmented or lacking, resulting in restrictive labeling…”
Get more information

A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial by Bandiera, Carole, Cardoso, Evelina, Locatelli, Isabella, Zaman, Khalil, Diciolla, Antonella, Digklia, Antonia, Stravodimou, Athina, Cristina, Valérie, Aedo-Lopez, Veronica, Dolcan, Ana, Sarivalasis, Apostolos, Bouchaab, Hasna, Pasquier, Jérôme, Dotta-Celio, Jennifer, Peters, Solange, Wagner, Dorothea, Csajka, Chantal, Schneider, Marie Paule

“…Oral anticancer therapies such as protein kinase inhibitors (PKIs) are increasingly prescribed in cancer care. We aimed to evaluate the impact of a…”
Get full text

Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies Study by Ravix, Anne, Bandiera, Carole, Cardoso, Evelina, Lata-Pedreira, Adrian, Chtioui, Haithem, Decosterd, Laurent Arthur, Wagner, Anna Dorothea, Schneider, Marie Paule, Csajka, Chantal, Guidi, Monia

“…Trametinib is a targeted therapy used for the treatment of solid tumours, with significant variability reported in real-life studies. This variability…”
Get full text

A population pharmacokinetic model for sertraline in women during the perinatal period—A contribution from the ConcePTION project by Monfort, Anaëlle, Cardoso, Evelina, Eap, Chin B., Ansermot, Nicolas, Crettol, Severine, Fischer Fumeaux, Céline J., Graz, Myriam Bickle, Harari, Mathilde Morisod, Weisskopf, Etienne, Gandia, Peggy, Allegaert, Karel, Annaert, Pieter, Nordeng, Hedvig, Hascoët, Jean‐Michel, Claris, Olivier, Epiney, Manuella, Ferreira, Ema, Leclair, Grégoire, Csajka, Chantal, Panchaud, Alice, Guidi, Monia

“…Aims Sertraline is frequently prescribed for mental health conditions in both pregnant and breastfeeding women. According to the limited available data, only…”
Get full text

Maternal drugs and breastfeeding: Risk assessment from pharmacokinetics to safety evidence - A contribution from the ConcePTION project by Cardoso, Evelina, Monfort, Anaëlle, Ferreira, Ema, Nordeng, Hedvig, Winterfeld, Ursula, Allegaert, Karel, Gandia, Peggy, Guidi, Monia, Panchaud, Alice

“…Human milk is the most appropriate form of nutrition for infants while taking medication during the postpartum period is common. Discontinuation of…”
Get more information

Therapeutic drug monitoring of targeted anticancer therapy by Decosterd, Laurent A, Widmer, Nicolas, Zaman, Khalil, Cardoso, Evelina, Buclin, Thierry, Csajka, Chantal

“…New oral targeted anticancer therapies are revolutionizing cancer treatment by transforming previously deadly malignancies into chronically manageable…”
Get full text

Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study by Bandiera, Carole, Locatelli, Isabella, Courlet, Perrine, Cardoso, Evelina, Zaman, Khalil, Stravodimou, Athina, Dolcan, Ana, Sarivalasis, Apostolos, Zurcher, Jean-Philippe, Aedo-Lopez, Veronica, Dotta-Celio, Jennifer, Peters, Solange, Guidi, Monia, Wagner, Anna Dorothea, Csajka, Chantal, Schneider, Marie P

“…The cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) palbociclib is administered orally and cyclically, causing medication adherence challenges. We evaluated…”
Get full text

Suivi thérapeutique pharmacologique à la 4 e journée de pharmacologie des anti-tumoraux by Allard, Marie, Rousseau, Benoît, Cardoso, Evelina, Bellesoeur, Audrey, Blanchet, Benoit

Get full text

Suivi thérapeutique pharmacologique à la 4e journée de pharmacologie des anti-tumoraux by Allard, Marie, Rousseau, Benoît, Cardoso, Evelina, Bellesoeur, Audrey, Blanchet, Benoit

Get full text

Therapeutic drug monitoring - 4th edition of the congress of pharmacology of anticancer drugs by Allard, Marie, Rousseau, Benoît, Cardoso, Evelina, Bellesoeur, Audrey, Blanchet, Benoit

Get more information

Infant exposure to Fluvoxamine through placenta and human milk: a case series - A contribution from the ConcePTION project by Monfort, Anaëlle, Cardoso, Evelina, Eap, Chin B, Fischer Fumeaux, Céline J, Graz, Myriam Bickle, Morisod Harari, Mathilde, Weisskopf, Etienne, Gandia, Peggy, Allegaert, Karel, Nordeng, Hedvig, Hascoët, Jean-Michel, Claris, Olivier, Epiney, Manuella, Csajka, Chantal, Guidi, Monia, Ferreira, Ema, Panchaud, Alice

“…IntroductionFluvoxamine is widely used to treat depression during pregnancy and lactation. However, limited data are available on its transfer to the fetus or…”
Get full text